Marie‐Laure Ozoux

Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment

Ger‐Jan C.M. Sanderink, C. Guimart, Marie‐Laure Ozoux et al. · Thrombosis Research · 2002 · 196 citations

Urology, Renal Function, Prophylactic Dose +9

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

Ger‐Jan Sanderink, A. Le Liboux, Navin Jariwala et al. · Clinical Pharmacology & Therapeutics · 2002 · 182 citations · Full text

Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study

Jack L. Martin, Edward T.A. Fry, Ger‐Jan C.M. Sanderink et al. · Catheterization and Cardiovascular Interventions · 2004 · 78 citations

Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy

Philippe Beauverger, Marie‐Laure Ozoux, Guillaume Bégis et al. · Cardiovascular Research · 2019 · 53 citations

The Oral Ca/Calmodulin-Dependent Kinase II inhibitor RA608 Improves Contractile Function and Prevents Arrhythmias in Heart Failure

Julian Mustroph, Marzena Drzymalski, Maria J. Baier et al. · ESC Heart Failure · 2020 · 27 citations · Full text